أخبار البصيرة AI News Intelligence
الذكاء الاصطناعي إيجابي تحليل ذكي آلي Google DeepMind Blog 02 نيسان 2026, 09:00

جيما 4: أذكى نموذج مفتوح للتفكير المعقد

أعلنت جوجل ديب مايند عن إطلاق نموذج جيما 4، أذكى النماذج المفتوحة حتى الآن، المصممة خصيصًا لمهام الاستنتاج المتقدمة وسير عمل الوكلاء الذكيين. يتميز النموذج بكفاءة عالية في معالجة المهام المعقدة بدقة وسرعة محسّنة. يُعتبر تطورًا رئيسيًا في مجال النماذج اللغوية المفتوحة متاحة للمجتمع البحثي والتطويري.

Gemma 4: Byte for byte, the most capable open models

لماذا يهم هذا الخبر؟

يُعزز إطلاق جيما 4 قدرة الباحثين والمطورين على بناء تطبيقات ذكية معتمدة على وكالات ذاتية التصرف، مما يسرّع الابتكار في مجال الذكاء الاصطناعي المفتوح ويقلل الاعتماد على النماذج المغلقة.

سياق الخبر

Gemma 4: Our most intelligent open models to date, purpose-built for advanced reasoning and agentic workflows.

فتح الخبر الأصلي
تغطية مرتبطة

المزيد من أخبار الذكاء الاصطناعي

The AI Slot Machine Effect: Why Generative Feeds Disrupt Deep Work And How to Reclaim Focus الذكاء الاصطناعي

The AI Slot Machine Effect: Why Generative Feeds Disrupt Deep Work And How to Reclaim Focus

You open a generative AI tool expecting a quick boost. Ten minutes later, you’re still there, refining a prompt for the fourth time. The task you started with has drifted off to the side somewhere. Sound familiar? Knowledge workers in 2026 are running into this more and more. It makes sense once you look at […] The post The AI Slot Machine Effect: Why Generative Feeds Disrupt Deep Work And How to Reclaim Focus appeared first on AI News .

AI 0/10
AI News
اقرأ المزيد ←
Bristol Myers Squibb buys Nvidia AI system for drug discovery الذكاء الاصطناعي

Bristol Myers Squibb buys Nvidia AI system for drug discovery

Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD built on the chipmaker’s Vera Rubin architecture to support artificial intelligence use across its drug discovery and development operations. The pharmaceutical company said it will be the first life sciences group to acquire a DGX SuperPOD based on Vera Rubin. Nvidia introduced the architecture earlier this […] The post Bristol Myers Squibb buys Nvidia AI system for drug discovery appeared first on AI News .

AI 0/10
AI News
اقرأ المزيد ←
Chinese open-weight models are cheap. Washington is deciding what that costs. الذكاء الاصطناعي

Chinese open-weight models are cheap. Washington is deciding what that costs.

Enterprises evaluating Chinese open-weight models this month face a question that has nothing to do with benchmarks: whether using one will still be straightforward in a year. Moonshot AI’s Kimi K3 arrived on July 16 as the largest open-weight model yet released, and within days it had reopened a policy argument in Washington that had […] The post Chinese open-weight models are cheap. Washington is deciding what that costs. appeared first on AI News .

AI 0/10
AI News
اقرأ المزيد ←